Average Co-Inventor Count = 13.87
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Array Biopharma Inc. (13 from 329 patents)
2. Eli Lilly and Company (3 from 4,447 patents)
16 patents:
1. 11998545 - Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
2. 11697647 - RET kinase inhibitors
3. 11648243 - Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
4. 11613533 - Compounds useful for inhibiting RET kinase
5. 11603374 - Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors
6. 11472802 - Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors
7. 10953005 - Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
8. 10881652 - Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
9. 10584124 - Crystalline forms
10. 10555944 - Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
11. 10441581 - Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
12. 10172845 - Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
13. 10172851 - Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
14. 10144734 - Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
15. 10137124 - Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors